睿智医药(300149.SZ)子公司拟5800万元参投产业基金 重点投资创新药

Core Viewpoint - The company, Ruizhi Pharmaceutical, is establishing a partnership to invest in the healthcare industry, focusing on innovative drugs and medical devices, which is expected to enhance its capital operation capabilities and competitiveness [1] Investment Partnership - Ruizhi Pharmaceutical's wholly-owned subsidiary, Beihai Ruizhi Venture Capital Co., Ltd., signed a partnership agreement with Shenzhen Investment Control Donghai Investment Co., Ltd. and other limited partners to establish a new investment fund [1] - The total committed capital for the partnership is 200 million yuan, with Beihai Ruizhi contributing 58 million yuan, representing 29% of the total [1] Focus on Healthcare Sector - The newly formed partnership will primarily invest in the healthcare sector, with a strong emphasis on innovative drugs [1] - The collaboration with professional investment institutions is expected to leverage their investment capabilities, funding advantages, and risk control abilities to enhance the company's operations in the innovative drug industry [1]